Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection.
Al-Obaidi MM, Gungor AB, Nematollahi S, Zangeneh TT, Bedrick EJ, Johnson KM, Low-Adegbija NE, Alam R, Rangan P, William Heise C, Ariyamuthu VK, Shetty A, Qannus AA, Murugapandian S, Ayvaci MMS, Anand PM, Tanriover B. Al-Obaidi MM, et al. Among authors: murugapandian s. Open Forum Infect Dis. 2022 Apr 12;9(7):ofac186. doi: 10.1093/ofid/ofac186. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35791354 Free PMC article.
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era.
Sridhara S, Gungor AB, Erol HK, Al-Obaidi M, Zangeneh TT, Bedrick EJ, Ariyamuthu VK, Shetty A, Qannus AA, Mendoza K, Murugapandian S, Gupta G, Tanriover B. Sridhara S, et al. Among authors: murugapandian s. PLoS One. 2023 Apr 28;18(4):e0279326. doi: 10.1371/journal.pone.0279326. eCollection 2023. PLoS One. 2023. PMID: 37115780 Free PMC article.
Drug-coated balloon in peripheral artery disease.
Shanmugasundaram M, Murugapandian S, Truong HT, Lotun K, Banerjee S. Shanmugasundaram M, et al. Among authors: murugapandian s. Cardiovasc Revasc Med. 2019 Apr;20(4):338-343. doi: 10.1016/j.carrev.2018.04.017. Epub 2018 Apr 21. Cardiovasc Revasc Med. 2019. PMID: 29730237
Glucose-Lowering Medications and Cardiovascular Outcomes.
Shanmugasundaram M, Pineda JRE, Murugapandian S. Shanmugasundaram M, et al. Among authors: murugapandian s. Curr Cardiol Rep. 2021 Mar 2;23(4):24. doi: 10.1007/s11886-021-01452-z. Curr Cardiol Rep. 2021. PMID: 33655453 Review.
Contemporary Monoclonal Antibody Utilization in Glomerular Diseases.
Mansour I, Murugapandian S, Tanriover B, Thajudeen B. Mansour I, et al. Among authors: murugapandian s. Mayo Clin Proc Innov Qual Outcomes. 2023 Jun 30;7(4):276-290. doi: 10.1016/j.mayocpiqo.2023.04.009. eCollection 2023 Aug. Mayo Clin Proc Innov Qual Outcomes. 2023. PMID: 37448529 Free PMC article. Review.